Management of low-grade dysplasia in Barrett's esophagus

Current Opinion in Gastroenterology

Volumn 28, Issue 4, 2012, Pages 370-376

  Wani, Sachin ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

ablation; Barrett's esophagus; dysplasia; esophageal adenocarcinoma; low grade dysplasia

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16; PROTEIN P53; PROTON PUMP INHIBITOR;

ANEUPLOIDY; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; CONFOCAL LASER MICROSCOPY; DISEASE COURSE; DISEASE SURVEILLANCE; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS DYSPLASIA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PERFORATION; ESOPHAGUS STRICTURE; FLOW CYTOMETRY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HETEROZYGOSITY LOSS; HIGH RESOLUTION ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTESTINE METAPLASIA; MULTICENTER STUDY (TOPIC); NARROW BAND IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLUX ESOPHAGITIS; REPRODUCIBILITY; REVIEW; RISK; SURVIVAL; THORAX PAIN; TREATMENT OUTCOME;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT;

EID: 84862301158     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328353af02     Document Type: Review

References (36)

1. Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med 2009; 361:2548-2556.
2. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140:e18-e52
3. Wani S, Mathur S, Sharma P. How to manage a Barrett's esophagus patient with low-grade dysplasia. Clin Gastroenterol Hepatol 2009; 7:27-32.
4. Wani S, Falk GW, Post J, et al. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology 2011; 141:1179-1186.
5. Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: A metaanalysis. Gastrointest Endosc 2008; 67:394-398.
6. Odze RD. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006; 59:1029-1038.
7. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation. Hum Pathol 2001; 32:368-378.
8. Wani S, Mathur SC, Curvers WL, et al. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett's dysplasia. Clin Gastroenterol Hepatol 2010; 8:783-788.
9. Curvers WL, Ten Kate FJ, Krishnadath KK, et al. Low-grade dysplasia in Barrett's esophagus: Overdiagnosed and underestimated. Am JGastroenterol 2010; 105:1523-1530.
10. Dulai GS, Shekelle PG, Jensen DM, et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Am J Gastroenterol 2005; 100:775-783.
11. Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study. Am J Gastroenterol 2003; 98:1931-1939.
12. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120:1607-1619.
13. Srivastava A, Hornick JL, Li X, et al. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 2007; 102:483-493.
14. Lim CH, Treanor D, Dixon MF, et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy 2007; 39:581-587.
15. De Jonge PJ, Van Blankenstein M, Looman CW, et al. Risk of malignant progression in patients with Barrett's oesophagus: A Dutch nationwide cohort study. Gut 2010; 59:1030-1036.
16. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365:1375-1383.
17. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4:566-572.
18. Sikkema M, Looman CW, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett's esophagus: A prospective cohort study. Am J Gastroenterol 2011; 106:1231-1238.
19. Skacel M, Petras RE, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000; 95:3383-3387.
20. Vieth M, Schubert B, Lang-Schwarz K, et al. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: A long-term histopathological follow-up study. Endoscopy 2006; 38:1201-1205.
21. Reid BJ, Prevo LJ, Galipeau PC, et al. Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 2001; 96:2839-2848.
22. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: The Prague C and M criteria. Gastroenterology 2006; 131:1392-1399.
23. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37:570-578.
24. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140:1084-1091.
25. Kara MA, Peters FP, Rosmolen WD, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: A prospective randomized crossover study. Endoscopy 2005; 37:929-936.
26. Sharma P, Bansal A, Hawes R, et al. Detection of metaplasia and neoplasia in patients with Barrett's esophagus using high-definition white light endoscopy versus narrow band imaging: A prospective, multicenter, randomized, crossover trial. Gastrointest Endosc 2009; 69:AB135.
27. Curvers WL, Herrero LA, Wallace MB, et al. Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus. Gastroenterology 2010; 139:1106-1114.
28. Sharma P, Meining AR, Coron E, et al. Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: Final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011; 74:465-472.
29. Gaddam S, Mathur SC, Singh M, et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol 2011; 106:1961-1969.
30. Wani S, Sayana H, Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2010; 71:147-166.
31. Peters FP, Brakenhoff KP, Curvers WL, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 2008; 67:604-609.
32. Sayana H, Wani S, Keighley J, et al. Endoscopic mucosal resection (EMR) as a diagnostic tool in Barrett's esophagus (BE) patients with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC): A systematic review. Gastroenterology 2008; 132:W1878.
33. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360:2277-2288.
34. Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011; 141:460-468.
35. Vaccaro BJ, Gonzalez S, Poneros JM, et al. Detection of intestinal metaplasia after successful eradication of Barrett's esophagus with radiofrequency ablation. Dig Dis Sci 2011; 56:1996-2000.
36. Inadomi JM, Somsouk M, Madanick RD, et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009; 136:2101-2114.